Biotech dealmaking is back — but smaller and more intimate. Deals disclosed in the early days of the new year indicate that ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ahead.